AppLovin Pops on Earnings Triumph
AppLovin (NASDAQ:APP) shares soared Thursday after the company reported earnings and revenue that beat expectations and announced the sale of its mobile gaming business.Earnings came in at $1.67 per share vs $1.45 per share expected, on Revenue: $1.48 billion vs $1.38 billion expected. The company logged $1.16 billion in first-quarter advertising sales, up from $678 million a year ago.AppLovin also agreed on Wednesday to sell its mobile gaming business to Tripledot Studios in a deal worth $400 million in cash considerations.The advertising tech company will also obtain a roughly 20% ownership stake in Tripledot Studios, which makes mobile games like Sudoko Friends, Puzzletime and Solitaire Classic. The deal is expected to close in the second quarter of 2025.AppLovin said it expects second-quarter sales in the range of $1.2 billion to $1.22 billion, trailing analyst expectations of $1.38 billion.The company reported first-quarter net income of $576 million, or $1.67 per share, up from $234 million, or 67 cents per share, in the same quarter of 2024.AppLovin’s total costs and expenses for the first quarter came in at $820.55 million, representing a 14% increase from the previous year during the same quarter.Shares in APP hiked $51.56, or 17%, first thing Thursday to $355.02.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


